Skip to content

Long-term effects of homeopathic medicine on chronic skin disease in adults

A longitudinal quantitative study documenting homoeopathic treatment outcomes in chronic dermatological conditions in adults using the Patient Response Assessment Tool after Homoeopathic Treatment version 2.0 (PRATHoT v.2.0) - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093536
Enrollment
300
Registered
2025-08-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: Individualized homeopathic medicines: The intervention is planned to involve administering indicated homeopathic medicines in centesimal potencies (CH). Each dose will consist of 3-
dosage and repetition will depend on the individuals requirements. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking, or brushing their teeth within

Sponsors

D N De Homoeopathic Medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Suffering from any chronic dermatological complaints. 2.Either sex or transgender

Exclusion criteria

Exclusion criteria: 1. Patients denying written informed consent. 2. Patient taking homoeopathic treatment for any chronic disease within the last 6 months. 3. Simultaneous participation in any other clinical trial. 4. Unconscious, differently abled, non-ambulatory, too sick for consultation, terminally or critically ill patients, mentally incompetent. 5. Pregnant, puerperal and lactating women 6. Self-reported immunocompromised state, AIDS, hepatitis etc. 7. Diagnosed and probable case of skin cancer

Design outcomes

Primary

MeasureTime frame
Patient Response Assessment Tool after Homeopathic Treatment (PRATHoT; version 2.0)Timepoint: After enrollment every month, up to 3 months

Secondary

MeasureTime frame
outcome related to impact on daily living (ORIDL) scoreTimepoint: After enrollment every month, up to 3 months;The Dermatology Life Quality Index (DLQI) scoreTimepoint: At baseline, monthly, up to 3 months

Countries

India

Contacts

Public ContactSangita Saha

D.N.DE Homoeopathic Medical college and hospital

mousuminath690@gmail.com9007711140

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026